Amgen announced closure of Seattle and Bothell facilities
On Jul. 29, 2014, Amgen announced the closure of facilities in Seattle and Bothell which resulted in the…
Amgen relocated its cancer research division to Seattle
On May 22, 2003, Amgen announced it was relocating its cancer research division to Seattle following its acquisition…
Biotechnology | Disease | FDA | Life Science News | Medicine | Therapeutics
Long-term efficacy and safety of etanercept was found in children with polyarticular-course juvenile rheumatoid arthritis
On Jan. 10, 2003, long-term efficacy and safety of etanercept (Enbrel) was found in children with polyarticular-course juvenile…
Immunex Corp. was acquired by Amgen
On Jul. 16, 2002, Amgen completed it’s acquisition of Immunex Corporation for $16 billion in stock and net…
The acquisition of Immunex by Amgen for $16 billion was announced
On Dec. 17, 2001, the acquisition of Immunex by Amgen was announced for $16 billion in stock and…
Immunex received FDA approval to market Enbrel for treatment of moderate to severe rheumatoid arthritis
On Nov. 10, 1998, Immunex announced that ENBREL(tm) (etanercept) had received approval from the U.S. Food and Drug…
Immunex dedicated its new manufacturing and development center
In 1998, Immunex dedicated its new manufacturing and development center. The 100,000 square foot complex broke ground in…
Immunex merged with American Cyanamid’s Lederle Oncology business
On Dec. 21, 1992, Immunex announced a merger agreement with American Cyanamid Company’s Lederle Oncology business. In Nov….
Targeted Genetics began human clinical testing using gene therapy to combat HIV infection
In 1993, Targeted Genetics, a subsidiary of the Immunex Corporation, became the first company to begin human clinical…
Immunex received FDA approval to market Leukine (GM-CSF) in the U.S.
In March 1991, Immunex announced it had received U.S. Food and Drug Administration (FDA) approval to market Leukine…
H. Stewart Parker founded Targeted Genetics Corp. in Seattle
In 1989, H. Stewart Parker became CEO of Targeted Genetics, an Immunex Corp. spin-off in Seattle. which specialized…
Immunex Corporation was founded
In 1981, Immunex Corporation was founded by Stephen Duzan, and Christopher Henney and Steven Gillis from the Hutchinson…